Every life sciences company, whether biotech, diagnostics, or medtech, hits key inflection points where hiring needs evolve faster than internal capacity. Early-stage firms may rely on founders and scientific leaders to make critical hires. But as funding milestones are reached and pipelines mature, the question emerges: Do we continue managing recruitment in-house, or is it time to bring in external expertise?
Recognizing these turning points is crucial for maintaining momentum without overextending internal resources or missing out on top talent.
The Early Build Phase: Hands-On, Founder-Led Hiring
In the earliest stages, resources are tight, culture is still forming, and leaders are deeply involved in every hire. Internal recruitment often looks like spreadsheets, networks, and referral-driven searches. At this phase, external partners can still add value, especially for specialized roles (CMC, regulatory affairs, or clinical development) where time-to-fill and expertise matter more than volume.
The inflection point arrives when ad-hoc hiring starts to slow progress or distract core leadership from mission-critical work.
The Growth Phase: Structure Meets Scale
Once a company secures Series B or C funding, hiring often accelerates when new departments form, headcount projections double, and compliance demands increase. This is when an internal talent acquisition team begins to make sense. Dedicated recruiters can embed within departments, represent the employer brand, and ensure consistency in candidate experience.
But even a well-staffed team can hit limits. High-volume hiring sprints, confidential executive searches, or new market expansions often stretch internal capacity or ability. Here, an external search partner acts as an extension of your team, providing surge capacity, specialized networks, and targeted outreach where needed most.
The Maturity Phase: Complexity and Specialization
As organizations mature, hiring complexity rises. You may be entering new therapeutic areas, global markets, or integrating after an acquisition. Internal recruiters know the business well, but they can’t always reach passive senior talent or build pipelines in unfamiliar domains.
External partners can complement this by focusing on high-impact leadership and niche technical roles, positions where confidentiality, precision, and industry insight are essential. Collaboration between internal and external teams creates a hybrid model that offers both speed and strategic depth.
How to Decide
When evaluating whether to build or partner, consider:
- Hiring velocity: Are internal resources keeping pace with demand?
- Role complexity: Do roles require specialized industry knowledge or confidential outreach?
- Strategic focus: Are leaders spending too much time recruiting instead of executing growth initiatives?
- Cost efficiency: Would external partnership reduce time-to-fill or mitigate the risk of a mis-hire?
Building the Right Model for Your Stage
There’s no one-size-fits-all approach to talent acquisition. What matters most is timing, knowing when your organization has reached an inflection point that demands a shift in approach. Life sciences success depends not just on innovation, but on assembling the right people at the right moments of growth.
If your company is approaching one of those turning points, GeneCoda® can help you assess your current strategy and design a balanced model that aligns with your goals. Contact us to discuss how an adaptive hiring approach can power your next phase of growth.
